van der Elst ME - Search Results

1

Impact of safety-related regulatory action on clinical practice: a systematic review.

Piening S, Haaijer-Ruskamp FM, de Vries JT, van der Elst ME, de Graeff PA, Straus SM, Mol PG. Piening S, et al. Among authors: van der elst me. Drug Saf. 2012 May 1;35(5):373-85. doi: 10.2165/11599100-000000000-00000. Drug Saf. 2012. PMID: 22480319 Review.

2

Comprehensive evaluation of post-approval regulatory actions during the drug lifecycle - a focus on benefits and risks.

Bloem LT, Karomi M, Hoekman J, van der Elst ME, Leufkens HGM, Klungel OH, Mantel-Teeuwisse AK. Bloem LT, et al. Among authors: van der elst me. Expert Opin Drug Saf. 2021 Nov;20(11):1433-1442. doi: 10.1080/14740338.2021.1952981. Epub 2021 Jul 15. Expert Opin Drug Saf. 2021. PMID: 34263667 Free article.

3

Influence of the use of functional foods enriched with phytosterols/-stanols on adherence to statin therapy.

Eussen SR, Bouvy ML, Rompelberg CJ, van der Elst ME, Garssen J, Oosterveld MH, de Boer A, de Gier JJ, van Kranen HJ, Klungel OH. Eussen SR, et al. Among authors: van der elst me. Pharmacoepidemiol Drug Saf. 2011 Aug;20(8):830-7. doi: 10.1002/pds.2168. Epub 2011 Jun 7. Pharmacoepidemiol Drug Saf. 2011. PMID: 21648012 Clinical Trial.

4

Safety learning from drugs of the same class: room for improvement.

Stefansdottir G, Knol MJ, Arnardottir AH, van der Elst ME, Grobbee DE, Leufkens HG, De Bruin ML. Stefansdottir G, et al. Among authors: van der elst me. Clin Pharmacol Ther. 2012 May;91(5):872-80. doi: 10.1038/clpt.2011.319. Epub 2012 Mar 28. Clin Pharmacol Ther. 2012. PMID: 22453192

5

The Role of the European Medicines Agency in the Safety Monitoring of COVID-19 Vaccines and Future Directions in Enhancing Vaccine Safety Globally.

Caplanusi I, Szmigiel A, van der Elst M, Schougaard Christiansen ML, Thirstrup S, Zaccaria C, Cappelli B, Genov G, Straus S. Caplanusi I, et al. Drug Saf. 2024 May;47(5):405-418. doi: 10.1007/s40264-024-01405-9. Epub 2024 Feb 23. Drug Saf. 2024. PMID: 38396269 Free PMC article.

6

A pharmaceutical care program to improve adherence to statin therapy: a randomized controlled trial.

Eussen SR, van der Elst ME, Klungel OH, Rompelberg CJ, Garssen J, Oosterveld MH, de Boer A, de Gier JJ, Bouvy ML. Eussen SR, et al. Among authors: van der elst me. Ann Pharmacother. 2010 Dec;44(12):1905-13. doi: 10.1345/aph.1P281. Epub 2010 Nov 30. Ann Pharmacother. 2010. PMID: 21119098 Clinical Trial.

7

Oral antithrombotic use among myocardial infarction patients.

van der Elst ME, Cisneros-Gonzalez N, de Blaey CJ, Buurma H, de Boer A. van der Elst ME, et al. Ann Pharmacother. 2003 Jan;37(1):143-6. doi: 10.1345/aph.1C038. Ann Pharmacother. 2003. PMID: 12503950

8

Drug therapy for prevention of recurrent myocardial infarction.

van der Elst ME, Buurma H, Bouvy ML, de Boer A. van der Elst ME, et al. Ann Pharmacother. 2003 Oct;37(10):1465-77. doi: 10.1345/aph.1C450. Ann Pharmacother. 2003. PMID: 14519050

9

Improving pharmacotherapy after myocardial infarction by group academic detailing using feedback data on a patient level.

van der Elst ME, Bouvy ML, de Blaey CJ, de Boer A. van der Elst ME, et al. Pharmacotherapy. 2006 Feb;26(2):254-9. doi: 10.1592/phco.26.2.254. Pharmacotherapy. 2006. PMID: 16466330

10

Effect of drug combinations on admission for recurrent myocardial infarction.

van der Elst ME, Bouvy ML, de Blaey CJ, de Boer A. van der Elst ME, et al. Heart. 2007 Oct;93(10):1226-30. doi: 10.1136/hrt.2006.098053. Epub 2007 May 13. Heart. 2007. PMID: 17502329 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

15 results

Search Page

Filters